Stay updated with breaking news from Primary Graft Dysfunction. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Journal of Lung and Heart Transplantation (JHLT) has published a real-world study indicating a significant reduction in Primary Graft Dysfunction (PGD), a severe post-transplant complication ― potentially allowing for an increase in donor hearts available for heart transplant patients
TransMedics Announces Positive FDA Advisory Committee Vote for OCS Heart System Panel votes 12 to 5 that benefits of OCS Heart System outweigh risks News provided by Share this article Share this article ANDOVER, Mass., April 6, 2021 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced today that after the review of TransMedics' clinical evidence from the OCS Heart EXPAND trial, the associated Continued Access Protocol ("CAP") res...